Delivery Order SPE2DB20D2104-SPE2DB25FMYPC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml units, with a contract ceiling value of $2,224.32. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ML quantities, with a ceiling value of $7,944.73 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 22, 2025. The award was issued to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $13,261.23 delivery order to AmerisourceBergen Drug Corp for dorzolamide-timolol eye drops (10mL) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dorzolamide HCL 2% eye drops in 10ml quantities, with a contract ceiling value of $1,342.34. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,486.64 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,110.96 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,446.16 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This contract uses firm fixed pricing and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a $3,495.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10mL units, with an ultimate completion date of September 15, 2025. This non-set-aside contract was competitively awarded on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $21,402 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on September 16, 2025, with completion expected by September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,663.23 firm fixed-price contract is for the delivery of 4567074296 - DORZOLAMIDE-TIMOLOL EYE DROPS 10ML. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYPCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen Drug Corp's extensive portfolio of pharmaceutical supply contracts supporting military and federal healthcare systems. As a major pharmaceutical distributor, the company maintains a $999.99 billion IDC with DLA Troop Support Medical running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/21/25 |